TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Solani Therapeutics Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
37
|
12 | |
| Financial expenses |
6
|
1
|
1 |
| Earnings before taxes |
-12
|
-9
|
-9 |
| Total assets |
167
|
134
|
144 |
| Current assets |
38
|
54
|
97 |
| Current liabilities |
40
|
45
|
46 |
| Equity capital |
77
|
90
|
99 |
| - share capital |
33
|
33
|
33 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
46.1%
|
67.2%
|
68.8% |
| Turnover per employee |
37
|
12 | |
| Profit as a percentage of turnover |
-32.4%
|
-75.0% | |
| Return on assets (ROA) |
-3.6%
|
-6.0%
|
-5.6% |
| Current ratio |
95.0%
|
120.0%
|
210.9% |
| Return on equity (ROE) |
-15.6%
|
-10.0%
|
-9.1% |
| Change turnover | 25 | ||
| Change turnover % | 208% | ||
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.